This is a routine debt settlement with no material impact on the company's operations or pipeline. Monitor for any future financing or pipeline updates, as the company remains a micro-cap biotech with no near-term catalysts announced.
Price Chart
Executive Summary
Quantum BioPharma settled CAD$123,487.43 in debt by issuing 30,948 Class B shares at CAD$3.99 per share to arm's length creditors and insiders. This small debt-for-equity swap is a routine capital management action for a micro-cap biotech, avoiding cash outlay but adding modest dilution. The filing lacks any operational or pipeline catalysts, making it a low-impact event.
Key Financial Metrics
Key Facts
- Settled CAD$123,487.43 in debt via issuance of 30,948 Class B shares at CAD$3.99 per share.
- Debt settlement involved both arm's length creditors and insiders.
- Shares were priced at the CSE closing price on the day prior to closing.
- No new operational, pipeline, or financial performance data was disclosed.
Financial Impact
CAD$123,487.43 debt settled; dilution of 30,948 shares (approximately 0.2% of outstanding based on market cap of $18M and share price).
Risk Factors
- Dilution from share issuance, though minimal in this instance.
- No pipeline or revenue catalysts disclosed; continued cash burn risk for a micro-cap biotech.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3335726 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $3.11 | awaiting T+20 | — | $2.21 (−28.94%) |
Oct 6, 2026 20d ago | 6-K | $3.09 | awaiting T+20 | — | $2.21 (−28.48%) |
Oct 6, 2026 20d ago | Press Release | $3.09 | awaiting T+20 | — | $2.21 (−28.48%) |
Oct 5, 2026 21d ago | SC 13G/A | $3.27 | awaiting T+20 | — | $2.21 (−32.42%) |
Sep 24, 2026 4w ago | 6-K | $4.00 $2.27 | ▼ −43.25% | ▼ −42.83% | $2.21 (−44.75%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.21 (−40.59%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.21 (−40.59%) |
Sep 15, 2026 5w ago | 6-K | $3.46 $2.89 | ▼ −16.47% | ▼ −19.45% | $2.21 (−36.13%) |
Sep 1, 2026 7w ago | 6-K | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.21 (−28.25%) |
Sep 1, 2026 7w ago | Press Release | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.21 (−28.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers